<DOC>
	<DOCNO>NCT01569334</DOCNO>
	<brief_summary>Heart transplantation best option patient end-stage heart failure . Cardiac allograft vasculopathy ( CAV ) lead cause death follow cardiac transplantation manage current therapy . Its pathogenesis traduces accelerate form coronary artery disease ( CAD ) similarities atherosclerosis also particular feature endothelial dysfunction associate alloimmune conflict humoral response toward graft . Intravascular ultrasound ( IVUS ) validate invasive method late CAV diagnosis , occur lesion establish . Identification reliable non-invasive early endothelial injury biomarkers reflect mechanisms cardiac damage thus remain major challenge optimize therapeutic management post transplant morbidity . Endothelial dysfunction central feature CAV CAD result desquilibrium balance endothelial lesion repair partly control recipient immune system . Through expression receptor sense antibody ( FcR CD16 ) endothelial stress-induced signal ( CX3CR1 fractalkine receptor NKG2D MICA receptor ) , Natural Killer ( NK ) cell represent effector cell unique potential generate humoral innate immune injury graft endothelium .</brief_summary>
	<brief_title>Identification Non Invasive Biomarkers Immune Endothelial Injury Repair Associated With Cardiac Allograft Vasculopathy</brief_title>
	<detailed_description />
	<mesh_term>Vascular Diseases</mesh_term>
	<criteria>Subject &gt; 18 year time inclusion , Subject benefit heart transplant 11 month ago service cardiac surgery concern whatever treatment immunosuppresseur current Subject benefiting coronarography within framework surveillance commentClerk 's Office beyond 12 month Subject give consent Affiliated Social Security * HTC Cardiac allograft vasculopathy : Subject coronaropathies diagnose coronarography * TC without Cardiac allograft vasculopathy : Subject without coronaropathies diagnose coronarography * untransplanted Untreated Subject immunosuppresseurs Subject without antécédaent transfusion Subject without history transplantation Subject coronaropathies diagnose coronarography Presenting contraindication coronarography Subject refuse practise examination coronarography Subject reach ( affect ) cancer one cutaneous Subject achieve hepatic Incapacity ( ALAT and\or ASAT &gt; 3N )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>identify early non invasive marker index endothelial lesion/ regeneration potential association CAV heart transplant recipient ( HTR )</keyword>
</DOC>